Using the serious mental illness health improvement profile [HIP] to identify physical problems in a cohort of community patients: A pragmatic case series evaluation

International Journal of Nursing Studies

Volumn 47, Issue 2, 2010, Pages 136-145

  Shuel, Francis ^a   White, Jacquie ^b   Jones, Martin ^c   Gray, Richard ^d  

^a WISHAW GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c SURREY AND BORDERS PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Assessment; Bipolar disorder; HIP; Metabolic syndrome; Nursing; Physical health; Schizophrenia; Serious mental illness

Indexed keywords

ADULT; ARTICLE; FEEDBACK SYSTEM; FEMALE; GENERAL PRACTITIONER; HEALTH STATUS; HUMAN; INTERVIEW; MALE; MENTAL DISEASE; NURSE; PSYCHIATRY; RETROSPECTIVE STUDY; UNITED KINGDOM;

ADULT; FEEDBACK; FEMALE; HEALTH STATUS; HUMANS; INTERVIEWS AS TOPIC; MALE; MENTAL DISORDERS; NURSES; PHYSICIANS, FAMILY; PSYCHIATRY; RETROSPECTIVE STUDIES; SCOTLAND;

EID: 74649085829     PISSN: 00207489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijnurstu.2009.06.003     Document Type: Article

References (34)

1. Austoker J. Breast self examination. British Medical Journal 1-2 (2003) 326
2. Barak. Breast cancer in women with serious mental illness. Schizophrenia Research 102 (2008) 249-253
3. Barnes T.R.E., Paton C., Cavanagh M.-R., Hancock E., Taylor D.M., and and on behalf of the UK Prescribing Observatory for Mental Health. A UK Audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophrenia Bulletin 33 6 (2007) 1397-1403
4. Blank M.B., Mandell D., Aiken L., and Hadley T. Co-occurrence of HIV and serious mental illness among Medicaid recipients. Psychiatric Services 53 (2002) 868-873
5. Brown S., Inskipp H., and Barraclough B. Causes of excess mortality of schizophrena. British Journal of Psychiatry 177 (2000) 212-217
6. Burns T., and Cohen A. item of service payments for general practitioner care of severely mentally illness persons: does the money matter?. British Journal of General Practice 48 (1998) 1415-1416
7. Brugha T., and Glover G. Process and health outcomes: need for clarity in systematic reviews of case management for severe mental disorders. Health Trends 30 (1998) 76-79
8. Department of Health. Choosing Health: Supporting the Physical Needs of People with Severe Mental Illness Commissioning Framework (2006), DH Publications, London
9. Department of Health. From Values to Action: The Chief Nursing Officer's Review of Mental Health Nursing (2006), DH Publications, London
10. Department of Health. NHS Next Stage Review (2008), DH Publications, London
11. Flanagan R.J. Side effects of clozapine and some other psychoactive drugs. Current Drug Safety 3 2 (2008) 115-122
12. Goff D.C., Sullivan L.M., McEvoy P., et al. A comparison of ten year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Research 80 (2005) 45-53
13. Gray R., Brewin E., Noak J., Wyke-Joseph J., and Sonik B. A review of the literature on HIV infection: implications for research, policy and clinical practice. Journal of Psychiatric and Mental Health Nursing 9 4 (2002) 405-410
14. Haddad P. Weight change with atypical antipsychotics in the treatment of schizophrenia. Journal of Psychopharmacology 19 Suppl. 6 (2005) 16-27
15. Harvey P.W. Adverse effects of prolactin in rodents and humans: breast and prostate cancer. Journal of Psychopharmacology 22 2 Suppl. (2008) 20-27
16. Kohen D., and Wildgust H.J. The evolution of hyperprolactinaemia as an entity in psychiatric patients. Journal of Psychopharmacology 22 2 Suppl. (2008) 6-11
17. Lawrence D.M., Holman C.D., Jablensky A.V., et al. Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980-1998. British Journal of Psychiatry 182 (2003) 31-36
18. Macklin P., Bishop D., Watkinson H., Gallagher P., and Ferrier N. Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. British Journal of Psychiatry 191 (2007) 23-29
19. McEvoy J.P., Meyer M., Goff D.C., Nasrallah H.A., Davis S.M., Sullivan L., et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research 80 (2005) 19-32
20. National Health Service Quality Improvement Scotland. Standards for Integrated Care Pathways for Mental Health (2007), NHS QIS, Edinburgh
21. National Institute for Clinical Excellence. Guidance on the Use of Newer (Atypical) Antipsychotic Drugs for the Treatment of Schizophrenia (2002), NICE, London Technology Appraisal Guidance No. 43
22. National Institute for Health Clinical Excellence. Bipolar Disorder: The Management of Bipolar Disorder in Adults Children and Adolescents in Primary Care (2006), NICE, London National Clinical Practice Guideline Number 38
23. National Institute for Health Clinical Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (2009), NICE, London National Clinical Practice Guideline Number 82
24. National Patient Safety Agency. National Research Ethics Service: Defining Research: Issue 3 (2008), National Patient Safety Agency, London
25. Paton C., Esop R., Young C., and Taylor D. Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs. Acta Psychiatrica Scandinavica 110 4 (2004) 299-305
26. Robson D., and Gray R. Serious mental illness and physical health problems: a discussion paper. International Journal of Nursing Studies 44 3 (2007) 457-466
27. Ryan M.C., Flanagan S., Kinsella U., et al. The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naïve patients with schizophrenia. Life Science 74 (2004) 1999-2008
28. Schoos R., and Cohen C.I. In: Meyer J.M., and Nasrallah H.A. (Eds). Medical Illness and Schizophrenia (2003), American Psychiatric Publishing, Vancouver
29. Scotland Public Health Observatory. Obesity in Scotland: An Epidemiology Briefing (2007), ScotPho, Edinburgh
30. Smith S., Yeomans D., and Bushe C.J.P. A well-being programme in severe mental illness. Reducing risk for physical ill-health: a post-programme service evaluation at 2 years. European Psychiatry 22 (2007) 413-418
31. The Health and Social Care Information Centre. Health Survey for England: Latest Trends (2008), The Health and Social Care Information Centre, London
32. Tourangeau R., and Smith T.W. Asking sensitive questions: the impact of data collection mode, question format and question context. Public Opinion Quarterly 60 (1996) 275-304
33. Walters J., and Jones I. Clinical questions and uncertainty-prolactin measurement in patients with schizophrenia and bipolar disorder. Journal of Psychopharmacology 22 2 Suppl. (2008) 82-89
34. White J., Gray R., and Jones M. Development of the serious mental illness health improvement profile [HIP]. Journal of Psychiatric and Mental Health Nursing 16 (2009) 493-498